at CNBC.com (Jan 14, 2015)
Biotech ETFs are near all-time highs despite overall market weakness, due to successful trials -...
Biotech ETFs are near all-time highs despite overall market weakness, due to successful trials - e.g. for Vertex's (VRTX) cystic fibrosis treatment - and because some investors are betting on deals occurring. One ETF that is doing particularly well this year is iShares Nasdaq Biotech (IBB). Others include XBI, FBT and BBH.
From other sites
at Benzinga.com (Jan 14, 2015)
at CNBC.com (Jan 13, 2015)
at Zacks.com (Jan 12, 2015)
at Benzinga.com (Jan 12, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs